Better Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Better Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2022.
  • Better Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $3K, unchanged year-over-year.
  • Better Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $7K.
  • Better Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$153K, a 200% decline from 2020.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7K +$160K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$153K -$306K -200% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $153K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.